| NEI Psychopharmacology Congress |
|
|
|
Optimizing Functional Outcomes in Schizophrenia: Managing Negative Symptoms, Cognitive Impairment, and Adverse Effects
Jonathan M Meyer, MD
While the majority of treatment options have focused on treating positive symptoms in schizophrenia, in order to strive for optimal functional outcomes, negative symptoms, and related cognitive deficits must be addressed. In this presentation, Dr. Jonathan Meyer presents current findings on evidence-based effective treatment strategies to manage negative and cognitive symptoms, adverse side effects, and the importance of monitoring plasma levels for optimal treatment results.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Keeping up With the Clinical Advances: Depression
Stephen M Stahl, MD, PhD
Our understanding of the neurobiology of depression has increased in recent years, there is recognition that the neurobiological substrates of depression may go beyond monoaminergic circuits. In this presentation, Dr. Stephen Stahl provides an update on novel antidepressant treatments that are recently available or in development, including the mechanisms of action that are thought to underlie their potential antidepressant effects.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Medical Comorbidity in Mood Disorders: The Link With Metabolic-Inflammatory Systems
Roger S McIntyre, MD, FRCPC
There is growing evidence that inflammation and metabolic factors such as adiposity may play important roles in the pathophysiology of mental illnesses. Psychiatric and the medical disorders should be considered when selecting treatment, so that treatment not only can avoid harm but can also potentially be selected to suit the specific comorbid population. In this presentation, Dr. Roger McIntyre will discuss how to select treatment strategies that take medical factors into consideration.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Keeping up With the Clinical Advances: Schizophrenia
Jonathan M Meyer, MD
Schizophrenia is a debilitating disease, and is often difficult to treat. Some of the most common obstacles to treatment are issues with adherence, effectiveness, and unwanted side effects. In this presentation, Dr. Jonathan Meyer discusses novel agents in development or recently FDA approved that may aid in many of these challenges.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Moving Toward the Future: New Developments in the Management of Tardive Dyskinesia
Laxman B. Bahroo, DO
Tardive dyskinesia (TD) is an ongoing concern for patients treated with antipsychotics. Discontinuation of antipsychotic treatment may offer the best chance of TD remission; however, alternative strategies of TD management must be employed in patients who require continued antipsychotic therapy. In this presentation, Dr. Laxman Bahroo discusses new strategies for treating and managing tardive dyskinesia.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Mood Disorders During Pregnancy and the Postpartum
Marlene P Freeman, MD
The accurate diagnosis and timely treatment of peripartum mood disorders is essential, yet requires consideration of both the mother's and the offspring's health. In this presentation, Dr. Marlene Freeman describes the potential risks associated with peripartum mental illness as well as the evidence base for the risks vs. benefits of treatment options.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|